Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Pepin

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Pharmaceutics|December 28, 2019
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory PerspectivesMark McAllister, Talia Flanagan, Karin Boon, et al.
British Journal of Clinical Pharmacology|April 25, 2022
Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjectsShringi Sharma, Xavier Pepin, Jean Cheung, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 2020
Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentaryMasoud Jamei, Bertil Abrahamsson, Jonathan Brown, et al.
Pharmaceutics|April 23, 2022
Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery ResearchStefan Senekowitsch, Philipp Schick, Bertil Abrahamsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2013
PBPK models for the prediction of in vivo performance of oral dosage formsEdmund S Kostewicz, Leon Aarons, Martin Bergstrand, et al.
Molecular Pharmaceutics|April 11, 2024
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary ReportClaire Mackie, Sumit Arora, Paul Seo, et al.
The AAPS Journal|February 13, 2019
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary ReportTycho Heimbach, Sandra Suarez-Sharp, Maziar Kakhi, et al.
Clinical Pharmacology in Drug Development|August 27, 2022
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump InhibitorsShringi Sharma, Xavier Pepin, Harini Burri, et al.
The AAPS Journal|June 15, 2023
Streamlining Food Effect Assessment - Are Repeated Food Effect Studies Needed? An IQ AnalysisFilippos Kesisoglou, Sumit Basu, Tejashree Belubbi, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary ReportNeil Parrott, Sandra Suarez-Sharp, Filippos Kesisoglou, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Pharmaceutics|December 28, 2019
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory PerspectivesMark McAllister, Talia Flanagan, Karin Boon, et al.
British Journal of Clinical Pharmacology|April 25, 2022
Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjectsShringi Sharma, Xavier Pepin, Jean Cheung, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 2020
Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentaryMasoud Jamei, Bertil Abrahamsson, Jonathan Brown, et al.
Pharmaceutics|April 23, 2022
Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery ResearchStefan Senekowitsch, Philipp Schick, Bertil Abrahamsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2013
PBPK models for the prediction of in vivo performance of oral dosage formsEdmund S Kostewicz, Leon Aarons, Martin Bergstrand, et al.
Molecular Pharmaceutics|April 11, 2024
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary ReportClaire Mackie, Sumit Arora, Paul Seo, et al.
The AAPS Journal|February 13, 2019
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary ReportTycho Heimbach, Sandra Suarez-Sharp, Maziar Kakhi, et al.
Clinical Pharmacology in Drug Development|August 27, 2022
Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump InhibitorsShringi Sharma, Xavier Pepin, Harini Burri, et al.
The AAPS Journal|June 15, 2023
Streamlining Food Effect Assessment - Are Repeated Food Effect Studies Needed? An IQ AnalysisFilippos Kesisoglou, Sumit Basu, Tejashree Belubbi, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary ReportNeil Parrott, Sandra Suarez-Sharp, Filippos Kesisoglou, et al.
Pageof 4